| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 21 | 2023 | 269 | 3.700 |
Why?
|
| Thermogenesis | 7 | 2023 | 122 | 1.750 |
Why?
|
| Lipogenesis | 6 | 2023 | 68 | 1.220 |
Why?
|
| Insulin | 10 | 2022 | 686 | 1.090 |
Why?
|
| Lipolysis | 4 | 2022 | 47 | 1.060 |
Why?
|
| Signal Transduction | 14 | 2023 | 3068 | 0.950 |
Why?
|
| Fatty Acid Synthases | 4 | 2023 | 24 | 0.910 |
Why?
|
| Adipose Tissue, Brown | 4 | 2020 | 119 | 0.810 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2023 | 17 | 0.800 |
Why?
|
| Adipose Tissue, White | 4 | 2020 | 87 | 0.770 |
Why?
|
| Adipocytes, Brown | 2 | 2021 | 45 | 0.730 |
Why?
|
| Obesity | 6 | 2023 | 1248 | 0.720 |
Why?
|
| Sympathetic Nervous System | 2 | 2019 | 35 | 0.670 |
Why?
|
| Adrenergic Agents | 1 | 2020 | 15 | 0.650 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 80 | 0.620 |
Why?
|
| Adipocytes, White | 2 | 2021 | 27 | 0.610 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 709 | 0.590 |
Why?
|
| 3T3-L1 Cells | 11 | 2018 | 90 | 0.560 |
Why?
|
| PPAR gamma | 5 | 2009 | 77 | 0.510 |
Why?
|
| Energy Metabolism | 2 | 2019 | 384 | 0.500 |
Why?
|
| Adipose Tissue | 4 | 2022 | 297 | 0.440 |
Why?
|
| Animals | 27 | 2023 | 20955 | 0.430 |
Why?
|
| Insulin Resistance | 4 | 2019 | 411 | 0.430 |
Why?
|
| Mice | 20 | 2023 | 10994 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2009 | 617 | 0.370 |
Why?
|
| Carrier Proteins | 3 | 2009 | 709 | 0.360 |
Why?
|
| Cyclic AMP | 3 | 2022 | 145 | 0.350 |
Why?
|
| Adipocytes, Beige | 2 | 2020 | 15 | 0.310 |
Why?
|
| Cachexia | 2 | 2018 | 12 | 0.280 |
Why?
|
| Caspases | 1 | 2009 | 176 | 0.270 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2004 | 43 | 0.260 |
Why?
|
| Glucose Intolerance | 2 | 2021 | 90 | 0.260 |
Why?
|
| Muscle Proteins | 2 | 2004 | 117 | 0.250 |
Why?
|
| Mice, Knockout | 5 | 2023 | 2138 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 174 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 59 | 0.230 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 47 | 0.220 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 204 | 0.210 |
Why?
|
| Uncoupling Protein 1 | 3 | 2020 | 50 | 0.200 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 115 | 0.200 |
Why?
|
| Palmitates | 1 | 2023 | 21 | 0.200 |
Why?
|
| Acetyl Coenzyme A | 1 | 2023 | 24 | 0.200 |
Why?
|
| Cytoskeleton | 1 | 2003 | 139 | 0.200 |
Why?
|
| Autophagosomes | 1 | 2023 | 13 | 0.200 |
Why?
|
| Fatty Acids | 3 | 2023 | 202 | 0.190 |
Why?
|
| Endocytosis | 1 | 2003 | 153 | 0.190 |
Why?
|
| Catecholamines | 1 | 2022 | 31 | 0.190 |
Why?
|
| Triglycerides | 3 | 2015 | 244 | 0.190 |
Why?
|
| Actins | 1 | 2003 | 261 | 0.190 |
Why?
|
| Lipid Metabolism | 3 | 2021 | 223 | 0.180 |
Why?
|
| Neurons | 2 | 2018 | 934 | 0.180 |
Why?
|
| Adiposity | 2 | 2018 | 83 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 342 | 0.160 |
Why?
|
| Glucose | 5 | 2006 | 471 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2016 | 125 | 0.160 |
Why?
|
| Glucose Transporter Type 4 | 5 | 2007 | 60 | 0.160 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 122 | 0.150 |
Why?
|
| Male | 9 | 2021 | 30322 | 0.150 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2018 | 5 | 0.140 |
Why?
|
| Cell Communication | 1 | 2019 | 132 | 0.140 |
Why?
|
| Body Temperature Regulation | 1 | 2018 | 21 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2019 | 67 | 0.140 |
Why?
|
| Biological Transport | 5 | 2006 | 291 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 3449 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 231 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 364 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2017 | 2177 | 0.140 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 13 | 0.130 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 35 | 0.130 |
Why?
|
| Neoplasms | 2 | 2018 | 1393 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 351 | 0.130 |
Why?
|
| RNA | 1 | 2020 | 429 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1297 | 0.130 |
Why?
|
| Homeostasis | 1 | 2019 | 370 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1164 | 0.120 |
Why?
|
| Macrophages | 2 | 2020 | 1053 | 0.120 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 1597 | 0.120 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 1999 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 155 | 0.110 |
Why?
|
| Cell Membrane | 4 | 2007 | 501 | 0.110 |
Why?
|
| Humans | 10 | 2023 | 64272 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2017 | 487 | 0.110 |
Why?
|
| COS Cells | 2 | 2004 | 175 | 0.100 |
Why?
|
| Mitochondria | 2 | 2008 | 383 | 0.100 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2013 | 22 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 283 | 0.100 |
Why?
|
| Models, Biological | 3 | 2009 | 1187 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2020 | 375 | 0.100 |
Why?
|
| RNA, Small Interfering | 5 | 2007 | 929 | 0.100 |
Why?
|
| Hypoglycemic Agents | 2 | 2005 | 221 | 0.100 |
Why?
|
| Prediabetic State | 1 | 2012 | 53 | 0.090 |
Why?
|
| RNA Interference | 2 | 2006 | 621 | 0.090 |
Why?
|
| Gene Silencing | 2 | 2005 | 405 | 0.090 |
Why?
|
| Phosphorylation | 4 | 2009 | 948 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2012 | 189 | 0.090 |
Why?
|
| Gene Deletion | 2 | 2018 | 312 | 0.090 |
Why?
|
| Liver | 1 | 2015 | 868 | 0.080 |
Why?
|
| Gene Expression | 3 | 2013 | 851 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 498 | 0.080 |
Why?
|
| Kinetics | 2 | 2009 | 766 | 0.080 |
Why?
|
| Caspase 6 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Inflammation | 3 | 2017 | 1162 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 869 | 0.070 |
Why?
|
| Caspase 8 | 1 | 2009 | 65 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2009 | 108 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 136 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2009 | 221 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 3 | 2007 | 674 | 0.070 |
Why?
|
| Time Factors | 3 | 2005 | 3725 | 0.070 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2007 | 20 | 0.070 |
Why?
|
| Phosphatidylinositols | 1 | 2007 | 52 | 0.070 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2007 | 13 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 23 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2007 | 28 | 0.070 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 62 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2009 | 417 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 705 | 0.060 |
Why?
|
| Protein Transport | 2 | 2007 | 405 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 149 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 217 | 0.060 |
Why?
|
| Qb-SNARE Proteins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2005 | 41 | 0.060 |
Why?
|
| Angiotensin II Type 2 Receptor Blockers | 1 | 2005 | 1 | 0.060 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2005 | 3 | 0.060 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2005 | 8 | 0.060 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 7 | 0.060 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2005 | 6 | 0.060 |
Why?
|
| src Homology Domains | 1 | 2005 | 21 | 0.060 |
Why?
|
| Deoxyglucose | 1 | 2005 | 32 | 0.060 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2005 | 24 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 43 | 0.060 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2005 | 40 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 46 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2005 | 25 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2009 | 1552 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2005 | 25 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 46 | 0.060 |
Why?
|
| Adipogenesis | 1 | 2006 | 79 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2005 | 103 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2005 | 85 | 0.050 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2004 | 7 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 432 | 0.050 |
Why?
|
| CHO Cells | 1 | 2004 | 189 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 20 | 0.050 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2003 | 2 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 210 | 0.050 |
Why?
|
| Sphingosine | 1 | 2003 | 20 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 150 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2003 | 26 | 0.050 |
Why?
|
| Cricetinae | 1 | 2004 | 368 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2003 | 166 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 130 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2003 | 46 | 0.050 |
Why?
|
| Transferrin | 1 | 2003 | 70 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 251 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2023 | 80 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 329 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 296 | 0.050 |
Why?
|
| Rats | 2 | 2003 | 2005 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 1622 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 746 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2237 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2003 | 261 | 0.050 |
Why?
|
| Endosomes | 1 | 2003 | 177 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2003 | 614 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 375 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 402 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 168 | 0.050 |
Why?
|
| Transfection | 1 | 2003 | 696 | 0.050 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 30 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 901 | 0.040 |
Why?
|
| Myosins | 1 | 2002 | 115 | 0.040 |
Why?
|
| Subcutaneous Fat | 1 | 2021 | 47 | 0.040 |
Why?
|
| 3T3 Cells | 3 | 2007 | 112 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 785 | 0.040 |
Why?
|
| Kidney | 1 | 2003 | 455 | 0.040 |
Why?
|
| Neuregulins | 1 | 2020 | 9 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2021 | 109 | 0.040 |
Why?
|
| Autophagy | 1 | 2023 | 231 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 183 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 176 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2004 | 634 | 0.040 |
Why?
|
| Denervation | 1 | 2020 | 19 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2020 | 51 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2013 | 386 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2020 | 109 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 119 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2021 | 1365 | 0.040 |
Why?
|
| Female | 2 | 2019 | 33383 | 0.040 |
Why?
|
| Protein Binding | 1 | 2003 | 1619 | 0.040 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2018 | 5 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 180 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 460 | 0.030 |
Why?
|
| Gene Editing | 1 | 2021 | 323 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 587 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 187 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 1223 | 0.030 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2016 | 7 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 7 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2016 | 21 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2016 | 20 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 94 | 0.030 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 153 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 626 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 85 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 205 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 191 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2012 | 116 | 0.020 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2009 | 29 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 92 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 874 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 945 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2007 | 30 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 398 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 197 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 340 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 374 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 436 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 15 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 2006 | 28 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 14 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 22 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2005 | 29 | 0.010 |
Why?
|
| trans-Golgi Network | 1 | 2005 | 8 | 0.010 |
Why?
|
| Glycolysis | 1 | 2005 | 57 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2007 | 325 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 271 | 0.010 |
Why?
|
| Adiponectin | 1 | 2005 | 37 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2005 | 2 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 86 | 0.010 |
Why?
|
| Losartan | 1 | 2005 | 19 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 235 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 3318 | 0.010 |
Why?
|
| Imidazoles | 1 | 2005 | 84 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 320 | 0.010 |
Why?
|
| Sheep | 1 | 2005 | 182 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2005 | 70 | 0.010 |
Why?
|
| Pyridines | 1 | 2005 | 114 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 625 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2003 | 18 | 0.010 |
Why?
|
| Edetic Acid | 1 | 2003 | 24 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 1160 | 0.010 |
Why?
|
| Sphingolipids | 1 | 2003 | 24 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 348 | 0.010 |
Why?
|
| Proteomics | 1 | 2005 | 294 | 0.010 |
Why?
|
| Magnesium | 1 | 2003 | 55 | 0.010 |
Why?
|
| Phospholipids | 1 | 2003 | 82 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 230 | 0.010 |
Why?
|
| Myosin Type I | 1 | 2002 | 7 | 0.010 |
Why?
|
| Cytosol | 1 | 2003 | 181 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 5528 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 395 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5341 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 6306 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 14663 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 17136 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 17923 | 0.010 |
Why?
|